banner add

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.

from NYT > Health https://ift.tt/fK1SDwL
via IFTTT

No comments

Evidence Against Drinking Has Grown. Will Federal Advice Change?

Officials in other countries are warning about the health hazards of alcohol in any amount. Americans are still told that moderate drinking ...

Theme images by PLAINVIEW. Powered by Blogger.